Compare Nvidia Corp (NVDA) vs Summit Therapeutics Inc (SMMT) Price & Performance

Nvidia CorpTrade

Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Nvidia Corp vs Summit Therapeutics Inc — how do they compare? Nvidia Corp trades at $206.3 (market cap $4.92T), while Summit Therapeutics Inc trades at $14.58 (market cap $10.48B). The key difference: Nvidia Corp is far larger — about 469.5× Summit Therapeutics Inc's market cap, and Nvidia Corp pays a 0.49% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.

	NVDA	SMMT
Market Cap	$4.92T	$10.48B
Sector	Technology	Health
52-Week High	$235.75	$29.32
52-Week Low	$165.17	$13.05
Enterprise Value	$4.86T	$9.90B
Dividend Yield	0.49%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nvidia Corp

NVIDIA (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamentals. Recent earnings beats and robust profitability margins highlight operational strength. The stock is supported by a consensus analyst price target of $325.86, though it faces technical resistance near $210.

Outlook remains positive driven by AI chip demand, but risks include competition and market volatility. Revenue growth acceleration and high institutional ownership suggest long-term potential, yet valuation multiples require sustained execution to justify further upside.

Summit Therapeutics Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVDA

Amplify CWP Growth & Income ETF offers 10.69% yield with tech focus, rated a BUY for income portfolios.Seeking Alpha · 7 hours agoBullish Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 8 hours agoNeutral Nvidia faces pressure from cheaper Chinese chips but bets on AI and emerging tech for growthSeeking Alpha · 8 hours agoNeutral View details →

SMMT

View details →

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.